Literature DB >> 15611126

Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway.

Lihong Yin1, Nabila Bennani-Baiti, C Thomas Powell.   

Abstract

Phorbol 12-myristate 13-acetate (PMA) potently induces apoptosis of LNCaP human prostate cancer cells. Here, we show that C4-2 cells, androgen-hypersensitive derivatives of LNCaP cells, also are sensitive to PMA-induced apoptosis. Previous reports have implicated activation of protein kinase C (PKC) isozymes alpha and delta in PMA-induced LNCaP apoptosis using overexpression, pharmacological inhibitors, and dominant-negative constructs, but have left unresolved if other isozymes are involved, if there are separate requirements for individual PKC isozymes, or if there is redundancy. We have resolved these questions in C4-2 cells using stable expression of short hairpin RNAs to knock down expression of specific PKC isozymes individually and in pairs. Partial knockdown of PKCdelta inhibited PMA-induced C4-2 cell death almost completely, whereas near-complete knockdown of PKCalpha had no effect. Knockdown of PKCepsilon alone had no effect, but simultaneous knockdown of both PKCalpha and PKCepsilon in C4-2 cells that continued to express normal levels of PKCdelta inhibited PMA-induced apoptosis. Thus, our data indicate that there is an absolute requirement for PKCdelta in PMA-induced C4-2 apoptosis but that the functions of PKCalpha and PKCepsilon in apoptosis induction are redundant, such that either one (but not both) is required. Investigation of PMA-induced events required for LNCaP and C4-2 apoptosis revealed that p38 activation is dependent on PKCdelta, whereas induction of retinoblastoma protein hypophosphorylation requires both PKC signaling pathways and is downstream of p38 activation in the PKCdelta pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611126     DOI: 10.1074/jbc.M405266200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Synthetic Lethality Induced by Loss of PKC δ and Mutated Ras.

Authors:  Tongbo Zhu; Lihua Chen; Wei Du; Takanori Tsuji; Changyan Chen
Journal:  Genes Cancer       Date:  2010-02

2.  A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.

Authors:  Jun Chen; Karthik V Giridhar; Liyong Zhang; Shuping Xu; Q Jane Wang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

3.  KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha.

Authors:  Ying Jiang; Michael Berk; Lisam Shanjukumar Singh; Haiyan Tan; Lihong Yin; C Thomas Powell; Yan Xu
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.

Authors:  Liqing Xiao; Masumi Eto; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

5.  Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.

Authors:  John Meshki; M Cecilia Caino; Vivian A von Burstin; Erin Griner; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

6.  PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.

Authors:  Joaquín Villar; Humair S Quadri; Insun Song; York Tomita; Oscar M Tirado; Vicente Notario
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

7.  Dual action of NSC606985 on cell growth and apoptosis mediated through PKCδ in prostatic cancer cells.

Authors:  Xin Wang; Chen Tan; Guo Wang; Jing-Jing Cai; Li-Ping Wang; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Int J Oncol       Date:  2017-09-27       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.